To investigate the impact of HMOX1 on prostate cancer cells, we used siRNA to knock down HMOX1. qPCR and Western blotting validated the efficiency of HMOX1 knockdown (Figures 2J–L). This evidence concerns the gene HMOX1 and prostate carcinoma.